Fulltext

Erratum to "Double-Blind, Randomized, Three-Armed, Placebo-Controlled, Clinical Investigation to Evaluate the Benefit and Tolerability of Two Dosages of IQP-AE-103 in Reducing Body Weight in Overweight and Moderately Obese Subjects"

Uebelhack R 1 , Bongartz U 1 , Seibt S 2 , Bothe G 2 , Chong PW 3 , De Costa P 4 Show all authors , Wszelaki N 3

Affiliations 

  • 1 Analyze & Realize GmbH, Weißenseer Weg 111, 10369 Berlin, Germany
  • 2 Analyze & Realize GmbH, Waldseeweg 6, 13467 Berlin, Germany
  • 3 Zaluvida Corporate Sdn Bhd, E-16 Plaza Mont Kiara, 2 Jalan Kiara, 50480 Kuala Lumpur, Malaysia
  • 4 InQpharm Group Sdn Bhd, E-16 Plaza Mont Kiara, 2 Jalan Kiara, 50480 Kuala Lumpur, Malaysia
J Obes, 2019 07 11;2019:6189724.
PMID: 31380115 DOI: 10.1155/2019/6189724

Abstract

[This corrects the article DOI: 10.1155/2019/3412952.].

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications